Business Wire India
Study Synopsis - The findings will impact the interventional treatment of elderly patients with MI, steering physicians to physiology-guided complete revascularization.
- Data from 1445 patients across 34 centres from Italy, Spain and Poland were analyzed.
SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on innovative patient care in cardiovascular segment, today announced late-breaking data of its stent
Supraflex Cruz at the ESC Congress 2023.
The study, conducted across 34 participating sites spanning Italy, Spain, and Poland, was unveiled during the ESC Congress 2023, marking a significant step for Supraflex Cruz in the interventional cardiology space.
Principal Investigator Dr Simone Biscaglia from University Hospital of Ferrara, Italy presented primary endpoint data at one year from this study at the ESC Congress 2023. A total of 1445 older (at least 75 years of age) patients with MI (with or without ST-segment elevation) and multivessel disease were enrolled in this study from July 18, 2019, to October 25, 2021.
The study was an investigator-initiated, multicenter, prospective randomized (1:1) trial, to compare a strategy of physiology-guided complete myocardial revascularization versus a culprit-only strategy.
Speaking more on the trial, Dr Simone Biscaglia said, “Our landmark study published in the prestigious New England Journal of Medicine is an important step forward in interventional cardiology. We were extremely pleased to demonstrate that physiology-guided complete revascularization with implantation of Supraflex Cruz stents led to a highly significant 27% reduction in cardiovascular events.”
The primary end point was the patient-oriented composite end point (POCE) of all-cause death, any MI, any stroke, and any revascularization at 1 year. Commenting more on the trial results, Study Chair Dr Gianluca Campo from the University Hospital of Ferrara, Italy said, “The FIRE trial addressed the lack of evidence for a revascularization strategy beyond culprit lesion treatment in older patients with a mean age of 81 years, with MI and multivessel disease. We proved our hypothesis that complete revascularization with Supraflex Cruz, guided by coronary physiology, yielded superior results to a culprit lesion only strategy in these patients.”
Chief Medical Officer at SMT, Dr Krishna Sudhir commented, “This trial is a game changer for the treatment of elderly patients with MI. At SMT we are delighted that Supraflex Cruz was chosen as the stent in
the study and showed excellent results with low event rates in an extremely high risk group of patients, optimally treated with physiology-guided complete revascularization.”
While complete revascularization is well documented in younger MI patients, its applicability and advantages in older patients with MI who are prone to having a higher risk of complications has been uncertain until this trial. The findings will influence the interventional treatment of elderly patients with MI, driving physicians to optimally treat with complete revascularization guided by physiology.
"Kalkine Media dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
deserunt mollit anim id est laborum."
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero
in 45 BC
"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium
do Kalkine que laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore
veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam
voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur
magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est,
qui do Kalkine Media quia dolor sit amet, consectetur, adipisci velit, sed quia non
numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat
voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis
suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum
iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur,
vel illum qui do Kalkine eum fugiat quo voluptas nulla pariatur?"
1914 translation by H. Rackham
"But I must explain to you how all this mistaken idea of denouncing pleasure and
praising pain was born and I will give you a complete account of the system, and
expound the actual teachings of the great explorer of the truth, the master-builder
of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it
is pleasure, but because those who do not know how to pursue pleasure rationally
encounter consequences that are extremely painful. Nor again is there anyone who
loves or pursues or desires to obtain pain of itself, because it is pain, but
because occasionally circumstances occur in which toil and pain can procure him some
great pleasure. To take a trivial example, which of us ever undertakes laborious
physical exercise, except to obtain some advantage from it? But who has any right to
find fault with a man who chooses to enjoy a pleasure that has no annoying
consequences, or one who avoids a pain that produces no resultant pleasure?"
1914 translation by H. Rackham
"But I must explain to you how all this mistaken idea of denouncing pleasure and
praising pain was born and I will give you a complete account of the system, and
expound the actual teachings of the great explorer of the truth, the master-builder
of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it
is pleasure, but because those who do not know how to pursue pleasure rationally
encounter consequences that are extremely painful. Nor again is there anyone who
loves or pursues or desires to obtain pain of itself, because it is pain, but
because occasionally circumstances occur in which toil and pain can procure him some
great pleasure. To take a trivial example, which of us ever undertakes laborious
physical exercise, except to obtain some advantage from it? But who has any right to
find fault with a man who chooses to enjoy a pleasure that has no annoying
consequences, or one who avoids a pain that produces no resultant pleasure?"